CN105944068A - Application of mulberry-ginger injection in preparing medicine for treating diarrhea and respiratory tract infection - Google Patents
Application of mulberry-ginger injection in preparing medicine for treating diarrhea and respiratory tract infection Download PDFInfo
- Publication number
- CN105944068A CN105944068A CN201610497964.0A CN201610497964A CN105944068A CN 105944068 A CN105944068 A CN 105944068A CN 201610497964 A CN201610497964 A CN 201610497964A CN 105944068 A CN105944068 A CN 105944068A
- Authority
- CN
- China
- Prior art keywords
- medicine
- injection
- point
- acupoint
- respiratory tract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides application of a mulberry-ginger injection in preparing a medicine for treating diarrhea and respiratory tract infection. The medicine is used for being injected to a point to treat the diarrhea and respiratory diseases, wherein the injected point of point injection is one or more points of Feishu point, Fengmen point, Quchi point, Zusanli point, Chize point, Yingxiang point, Guanyuan point, Tianshu point, Tanzhong point, Tiantu point, Dingchuan point, Jianjing point and Renying point. The test results of clinical cases show that the medicine has an obvious curative effect on the diarrhea and respiratory tract infected diseases after being used for the point injection.
Description
Technical field
The invention belongs to field of medicaments, be specifically related to a kind of mulberry leaf-ginger common cold injection in preparation treatment
Application in diarrhoea and respiratory tract infection medicine.
Background technology
Respiratory tract infection is divided into upper respiratory tract infection and lower respiratory infection.Upper respiratory tract infection is
Refer to the acutely inflamed general name between nasal cavity to throat, be modal infectious disease.Under
Respiratory tract infection is modal infectious disease, must clearly cause the cause of disease of infection during treatment
Body is to select effective antibiotic.Upper respiratory tract infection about 90% is caused by virus, antibacterial sense
After dye is often secondary to virus infection.These disease four seasons, any age all can fall ill, by containing
Virus the spittle, droplet, or through pollute apparatus propagate.Often reduce in Abwehrkraft des Koepers
Time, as caught cold, tired, the situation such as drench with rain, the former virus existed or invaded by the external world or/
And antibacterial, mushroom out breeding, cause infecting.This disease prognosis bona, has self limiting, typically
Recovery from illness in 5-7 days.Chang Jifa bronchitis, pneumonia, nasal sinusitis, a few peoples can complicated with acute
Myocarditis, nephritis, rheumatic fever etc..Respiratory tract infection is modal infectious disease, treatment
Shi Bixu clearly cause the pathogen of infection to select effective antibiotic, but in prior art,
Treatment respiratory tract disease uses Western medicine mostly, and mostly uses the mode taken, and medicine enters
Arriving focus after digestive system again, the therapeutic effect reached has substantially reduced, therefore,
Treatment is slow, and human body is easily had side effects by Western medicine, slow curative effect.
Mulberry leaf-ginger common cold injection is widely used in flu, cough, laryngopharynx swelling and pain etc. clinically and exhales
Inhale tract disease, the most also there is scattered wind heat clearing away, effect of expelling phlegm for arresting cough.But existing injection
Agent also exists the problem that treatment is time-consuming and inconvenient in clinical treatment, and during intramuscular injection, patient is past
Toward may feel that pain, especially child.So patient also exists inadaptable for intramuscular injection
Property, secondly the disposable dosage of intramuscular injection is relatively big, occurs that the probability of untoward reaction also just increases
Greatly.
Summary of the invention
For intramuscular injection single use amount in current mulberry leaf-ginger common cold injection clinical treatment relatively
Greatly, patient's technical problem unconformable to intramuscular injection medication, the invention provides a kind of Mulberry Rhizoma Zingiberis Recens
Cold treating injection application in preparation treatment diarrhoea and respiratory tract infection medicine.
Described medicine is the medicine treating diarrhoea and respiratory system disease for acupoint injection therapy.
The injection acupuncture point of described acupoint injection therapy is feishu cave, FENGMEN acupoint, Quchi acupoint, tsu san li
Cave in cave, chize cave, fragrant cave, Guanyuan acupoint, TIANSHU acupoint (ST25), wingceltis, TIANTU acupoint, DINGCHUAN acupoint,
One or more acupuncture points in Jianjing point, Renying point.
Respiratory tract infection of the present invention includes upper respiratory tract infection, lower respiratory infection.
Medicine of the present invention is the medicine for the treatment of respiratory tract infection.
Described medicine constituent and content thereof are mulberry leaf-ginger common cold injection 0.25～2ml.
Described medicine constituent and content thereof are mulberry leaf-ginger common cold injection 0.25～2ml, peace
Pain determines 0.5～1ml.
Medicine of the present invention is the anti-diarrhea drug for the treatment of.
Described medicine constituent and content thereof are mulberry leaf-ginger common cold injection 0.25～2ml.
Described medicine is mulberry leaf-ginger common cold injection and Polyinosinic injection and vitamin B12 note
Penetrate one or both compositions in liquid.
Further, described medicine composition and content thereof are mulberry leaf-ginger common cold injection 0.25～2ml,
Polyinosinic injection 0.1～0.5ml.
Further, described medicine composition and content thereof are mulberry leaf-ginger common cold injection 0.25～2ml,
Alpha Vee-12 0.5～1ml.
Mulberry leaf-ginger common cold injection of the present invention is to be reached China's limited public affairs of Yu's pharmacy by Shanxi Canon
Department produces.
According to clinical verification, medicine of the present invention is for type Treated with Point-injection Therapy diarrhoea and respiratory tract
Catching, cure rate is high, and curative effect is fast, and patient adaptability is strong.
Detailed description of the invention
The raw material, the equipment that use in the specific embodiment of the invention are known product, by purchasing
Buy commercially available prod to obtain.
Below by way of relevant case, beneficial effects of the present invention is described.
Case one
1. data
Liu so-and-so, man, 31 years old.
Main suit: heating, throat discomfort 3 days
History of present illness: heating occurs in patient after suffering from cold before 3 days, high fever reaches 38.7 DEG C, companion
Have nasal obstruction, stream thin nasal discharge and throat discomfort, without cough, expectoration, without dizzy, headache, without uncomfortable in chest,
The discomforts such as tachypnea.
History of past illness: without special medical history.
Physical examination: show no obvious abnormalities.
Diagnosis: acute upper respiratory tract infection.
2. treatment and medication
Give medicine of the present invention: acupoint injection therapy medicine: mulberry leaf-ginger common cold injection (Shanxi
Da Hua Yu pharmaceutical Co. Ltd of Canon produces) 2ml.
Wherein, injection acupuncture point: bilateral Quchi acupoint, once a day.
3. the standard of curative effect evaluation
Curing: temperature recovery is normal, relevant clinical symptoms all disappears；Effective: under body temperature
It is down to normal, most of clinical symptom disappearance, still leave over minority clinical symptoms；Take a turn for the better: body temperature
With having declined, but do not recover to normal value, with or be not accompanied by relevant clinical symptoms；Invalid:
Body temperature is the most down or up, with or be not accompanied by relevant clinical symptoms.
4. curative effect
In injection, once evening on the same day, symptom alleviated patient afterwards, injected recovery from illness in 3 days.
Case two
1. data
Huang, man, 41 years old.
Main suit: generate heat, cough 2 days.
History of present illness: heating occurs in patient after suffering from cold before 2 days, high fever reaches 39.2 DEG C, companion
There are nasal obstruction, stream thin nasal discharge, with cough, cough thick sputum crudum, suck cold air postemphasis, nothing
Dizzy, headache, without discomforts such as uncomfortable in chest, tachypneas.Once ibuprofen antipyretic treatment, less effective were given.
History of past illness: without special medical history.
Physical examination: show no obvious abnormalities.
Diagnosis: acute upper respiratory tract infection.
2. treatment and medication
Give medicine of the present invention: acupoint injection therapy medicine: mulberry leaf-ginger common cold injection (Shanxi
Da Hua Yu pharmaceutical Co. Ltd of Canon produces) 2ml+ Components In Antongding Injectate 1ml.
Wherein, injection acupuncture point: bilateral Quchi acupoint, once a day.
3. the standard of curative effect evaluation
Curing: temperature recovery is normal, relevant clinical symptoms all disappears；Effective: under body temperature
It is down to normal, most of clinical symptom disappearance, still leave over minority clinical symptoms；Take a turn for the better: body temperature
With having declined, but do not recover to normal value, with or be not accompanied by relevant clinical symptoms；Invalid:
Body temperature is the most down or up, with or be not accompanied by relevant clinical symptoms.
4. curative effect
In injection, once evening on the same day, symptom alleviated patient afterwards, injected recovery from illness in 4 days.
Case three
1. data
Huang, man, 36 years old.
Main suit: generate heat, cough 3 days.
History of present illness: heating occurs in patient after suffering from cold before 3 days, high fever reaches 38.3 DEG C, companion
There are nasal obstruction, stream thin nasal discharge, with cough, cough dilute expectorant, without dizzy, headache, without uncomfortable in chest, tachypnea
Deng uncomfortable.
History of past illness: without special medical history.
Physical examination: show no obvious abnormalities.
Diagnosis: acute upper respiratory tract infection.
2. treatment and medication
Give medicine of the present invention: acupoint injection therapy medicine: mulberry leaf-ginger common cold injection (Shanxi
Da Hua Yu pharmaceutical Co. Ltd of Canon produces) 2ml.
Wherein, injection acupuncture point: the bilateral tsusanli acupoint, once a day.
3. the standard of curative effect evaluation
Curing: temperature recovery is normal, relevant clinical symptoms all disappears；Effective: under body temperature
It is down to normal, most of clinical symptom disappearance, still leave over minority clinical symptoms；Take a turn for the better: body temperature
With having declined, but do not recover to normal value, with or be not accompanied by relevant clinical symptoms；Invalid:
Body temperature is the most down or up, with or be not accompanied by relevant clinical symptoms.
4. curative effect
In injection, once evening on the same day, symptom alleviated patient afterwards, injected recovery from illness in 2 days.
Case four
1. data
Huang, man, 27 years old.
Main suit: generate heat, cough 3 days
History of present illness: patient heating occurs after blowing air-conditioning between 3 day eve, and high fever reaches 38.6 DEG C,
With nasal obstruction, stream thin nasal discharge, with cough, cough dilute expectorant, time serious, have dizziness, no headache, nothing
Uncomfortable in chest, tachypnea, without discomforts such as Nausea and vomiting.
History of past illness: without special medical history.
Physical examination: show no obvious abnormalities.
Diagnosis: acute upper respiratory tract infection.
2. treatment and medication
Give medicine of the present invention: acupoint injection therapy medicine: mulberry leaf-ginger common cold injection (Shanxi
Da Hua Yu pharmaceutical Co. Ltd of Canon produces) 2ml.
Wherein, injection acupuncture point: bilateral chize cave, once a day.
3. the standard of curative effect evaluation
Curing: temperature recovery is normal, relevant clinical symptoms all disappears；Effective: under body temperature
It is down to normal, most of clinical symptom disappearance, still leave over minority clinical symptoms；Take a turn for the better: body temperature
With having declined, but do not recover to normal value, with or be not accompanied by relevant clinical symptoms；Invalid:
Body temperature is the most down or up, with or be not accompanied by relevant clinical symptoms.
4. curative effect
In injection, once evening on the same day, symptom alleviated patient afterwards, injected recovery from illness in 3 days.
Case five
1. data
Zhu, man, 35 years old.
Main suit: generate heat 3 days
History of present illness: patient occurs generating heat after suffering from cold before 3 days, high fever 38.3 DEG C, companion's nasal obstruction,
Stream thin nasal discharge, without dizzy, headache, without uncomfortable in chest, tachypnea, without discomforts such as Nausea and vomiting.Do not give
Special treatment.
History of past illness: without special medical history.
Physical examination: show no obvious abnormalities.
Diagnosis: acute upper respiratory tract infection.
2. treatment and medication
Give medicine of the present invention: acupoint injection therapy medicine: mulberry leaf-ginger common cold injection (Shanxi
Da Hua Yu pharmaceutical Co. Ltd of Canon produces) 2ml.
Wherein, injection acupuncture point: bilateral fragrant cave, once a day.
3. the standard of curative effect evaluation
Curing: temperature recovery is normal, relevant clinical symptoms all disappears；Effective: under body temperature
It is down to normal, most of clinical symptom disappearance, still leave over minority clinical symptoms；Take a turn for the better: body temperature
With having declined, but do not recover to normal value, with or be not accompanied by relevant clinical symptoms；Invalid:
Body temperature is the most down or up, with or be not accompanied by relevant clinical symptoms.
4. curative effect
In injection, once evening on the same day, symptom alleviated patient afterwards, injected recovery from illness in 2 days.
Case six
1. data
Yang, man, 3 years old.
Main suit: suffer from diarrhoea 2 days.
History of present illness: heating occurred in patient before 2 days, body temperature is the highest 38.5 DEG C, with vomiting, abdomen
Rush down, become greatly egg flower sample, amount many, every day about 10 times, oliguria, do not give special treatment.
History of past illness: without special medical history.
Physical examination: spirit is not good enough, and xerocheilia, auscultation of lung is without exception, and abdomen is put down soft, intestinal
Ring sound 10 beats/min.
Diagnosis: acute diarrhea.
2. treatment and medication
Give medicine of the present invention: acupoint injection therapy medicine: mulberry leaf-ginger common cold injection (Shanxi
Da Hua Yu pharmaceutical Co. Ltd of Canon produces) (Jinan Wei Erkang is biochemical for 2ml+ Polyinosinic injection
Pharmaceutical Co. Ltd produces) 0.5ml.
Wherein, injection acupuncture point: the tsusanli acupoint and Guanyuan acupoint, once a day, oral benefit salt simultaneously
Liquid.
3. the standard of curative effect evaluation
Curing: temperature recovery is normal, relevant clinical symptoms all disappears；Effective: under body temperature
It is down to normal, most of clinical symptom disappearance, still leave over minority clinical symptoms；Take a turn for the better: body temperature
With having declined, but do not recover to normal value, with or be not accompanied by relevant clinical symptoms；Invalid:
Body temperature is the most down or up, with or be not accompanied by relevant clinical symptoms.
4. curative effect
Patient's symptom of diarrhea after injecting twice substantially alleviates, and injects recovery from illness in 5 days.
Case seven
1. data
Zhang, man, 2.5 years old.
Main suit: suffer from diarrhoea 2 days.
History of present illness: patient occurred before 2 days diarrhoea, greatly become egg flower sample, amount many, every day about 6
8 times, with vomiting, low grade fever, without substantially stomachache, without cough, expectoration, without dizzy, head
The discomforts such as pain.Do not give special treatment.
History of past illness: without special medical history.
Physical examination: spirit is not good enough, and auscultation of lung is without exception, and abdomen is put down soft, borborygmus 9 times/
Point.
Diagnosis: acute diarrhea.
2. treatment and medication
Give medicine of the present invention: acupoint injection therapy medicine: mulberry leaf-ginger common cold injection (Shanxi
Da Hua Yu pharmaceutical Co. Ltd of Canon produces) 2ml+ Alpha Vee-12 (Mt. Tiantai, Chengdu
Pharmaceutical Co. Ltd) 0.5ml.
Wherein, injection acupuncture point: the tsusanli acupoint and TIANSHU acupoint (ST25), once a day.
3. the standard of curative effect evaluation
Curing: temperature recovery is normal, relevant clinical symptoms all disappears；Effective: under body temperature
It is down to normal, most of clinical symptom disappearance, still leave over minority clinical symptoms；Take a turn for the better: body temperature
With having declined, but do not recover to normal value, with or be not accompanied by relevant clinical symptoms；Invalid:
Body temperature is the most down or up, with or be not accompanied by relevant clinical symptoms.
4. curative effect
Patient's symptom of diarrhea after injecting twice substantially alleviates, and injects recovery from illness in 5 days.
Case eight
1. data
King so-and-so, man, 4 years old.
Main suit: suffer from diarrhoea 1 day.
History of present illness: patient occurred before 1 day diarrhoea, greatly become egg flower sample, amount many, every day about 5～
7 times, low grade fever, without substantially stomachache, without cough, expectoration, without discomforts such as dizziness, headaches.Not
Give special treatment.
History of past illness: without special medical history.
Physical examination: spirit is not good enough, and auscultation of lung is without exception, and abdomen is put down soft, borborygmus 7～9
Beat/min.
Diagnosis: acute diarrhea.
2. treatment and medication
Give medicine of the present invention: acupoint injection therapy medicine: mulberry leaf-ginger common cold injection (Shanxi
Da Hua Yu pharmaceutical Co. Ltd of Canon produces) 2ml.
Wherein, injection acupuncture point: the tsusanli acupoint, once a day.
3. the standard of curative effect evaluation
Curing: temperature recovery is normal, relevant clinical symptoms all disappears；Effective: under body temperature
It is down to normal, most of clinical symptom disappearance, still leave over minority clinical symptoms；Take a turn for the better: body temperature
With having declined, but do not recover to normal value, with or be not accompanied by relevant clinical symptoms；Invalid:
Body temperature is the most down or up, with or be not accompanied by relevant clinical symptoms.
4. curative effect
Patient's symptom of diarrhea after injection once substantially alleviates, and injects recovery from illness in 3 days.
To sum up case, medicine of the present invention is used for acupoint injection therapy, for respiratory tract infection and
That suffers from diarrhoea is evident in efficacy.
Claims (10)
1. mulberry leaf-ginger common cold injection application in preparation treatment diarrhoea and respiratory tract infection medicine.
Application the most according to claim 1, it is characterised in that described medicine be for
Acupoint injection therapy treats the medicine of diarrhoea and respiratory system disease.
Application the most according to claim 2, it is characterised in that described acupoint injection therapy
Injection acupuncture point be feishu cave, FENGMEN acupoint, Quchi acupoint, the tsusanli acupoint, chize cave, fragrant cave,
In Guanyuan acupoint, TIANSHU acupoint (ST25), wingceltis in cave, TIANTU acupoint, DINGCHUAN acupoint, Jianjing point, Renying point one
Plant or multiple acupuncture point.
Application the most according to claim 1 and 2, it is characterised in that described respiratory tract
Infection includes upper respiratory tract infection, lower respiratory infection.
5. the medicine described in an application as claimed in claim 1, it is characterised in that institute
The medicine stated is the medicine for the treatment of respiratory tract infection.
Medicine the most according to claim 5, it is characterised in that described medicine forms into
Divide and content is mulberry leaf-ginger common cold injection 0.25～2ml.
Medicine the most according to claim 5, it is characterised in that described medicine forms into
Divide and content is mulberry leaf-ginger common cold injection 0.25～2ml, antondin 0.5～1ml.
8. the medicine described in an application as claimed in claim 1, it is characterised in that institute
The medicine stated is the medicine for the treatment of diarrhoea.
Medicine the most according to claim 8, it is characterised in that the composition of described medicine
Composition and content thereof are mulberry leaf-ginger common cold injection 0.25～2ml.
Medicine the most according to claim 8, it is characterised in that described medicine is Mulberry
One or both in Rhizoma Zingiberis Recens cold treating injection and Polyinosinic injection and Alpha Vee-12
Composition；
Further, described medicine composition and content thereof are mulberry leaf-ginger common cold injection 0.25～2ml,
Polyinosinic injection 0.1～0.5ml；
Further, described medicine composition and content thereof are mulberry leaf-ginger common cold injection 0.25～2ml,
Alpha Vee-12 0.5～1ml.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610497964.0A CN105944068A (en) | 2016-06-29 | 2016-06-29 | Application of mulberry-ginger injection in preparing medicine for treating diarrhea and respiratory tract infection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610497964.0A CN105944068A (en) | 2016-06-29 | 2016-06-29 | Application of mulberry-ginger injection in preparing medicine for treating diarrhea and respiratory tract infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105944068A true CN105944068A (en) | 2016-09-21 |
Family
ID=56901790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610497964.0A Withdrawn CN105944068A (en) | 2016-06-29 | 2016-06-29 | Application of mulberry-ginger injection in preparing medicine for treating diarrhea and respiratory tract infection |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105944068A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104922620A (en) * | 2014-11-28 | 2015-09-23 | 山西佳能达华禹制药有限公司 | Application of Sang Jiang Cold Injection (mulberry leaf and ginger cold injection) to preparation of aerosolization and rectal administration preparation and preparation method of Sang Jiang Cold Injection |
-
2016
- 2016-06-29 CN CN201610497964.0A patent/CN105944068A/en not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104922620A (en) * | 2014-11-28 | 2015-09-23 | 山西佳能达华禹制药有限公司 | Application of Sang Jiang Cold Injection (mulberry leaf and ginger cold injection) to preparation of aerosolization and rectal administration preparation and preparation method of Sang Jiang Cold Injection |
Non-Patent Citations (3)
| Title |
|---|
| 潘明继: "《癌症扶正培本治疗学》", 31 March 2003, 复旦大学出版社 * |
| 白吉焕等: "维生素B12止泻穴注射治疗婴幼儿腹泻", 《山西护理杂志》 * |
| 雒荣东: "穴位注射治疗婴幼儿秋季腹泻的对照观察", 《中国针灸》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103394070B (en) | Treat grippal Chinese medicine preparation | |
| CN106668832B (en) | Application of polypeptide in preparation of medicine for treating enterovirus infection | |
| CN104257794B (en) | Chinese medicine composition of a kind of spleen reinforcing removing food stagnancy and preparation method thereof | |
| CN103599352A (en) | Medicine for treating acute laryngopharyngitis | |
| CN108542961A (en) | Injection agent of cordate houttuynia and honeysuckle is used to prepare the purposes of rectally preparation and Neulized inhalation preparation | |
| CN107669881A (en) | A kind of Chinese medicine for treating acute bronchitis in children | |
| CN103638488B (en) | One treats pleuritic Chinese medicine composition | |
| CN104306793B (en) | A kind of Chinese medicine preparation for treating lobar pneumonia | |
| CN103041250A (en) | Pharmaceutical composition for treating tuberculosis | |
| CN105944068A (en) | Application of mulberry-ginger injection in preparing medicine for treating diarrhea and respiratory tract infection | |
| CN104257795A (en) | Medicine for treating cold | |
| CN103845669A (en) | Traditional Chinese medicine for treating phthisis | |
| CN103340986B (en) | Traditional Chinese medicine enema for treating hand-foot-and-mouth disease of children | |
| CN105879000A (en) | Pharmaceutic preparation for treating tonsillitis and application thereof | |
| CN102228560B (en) | Medicine for treating chronic pharyngitis | |
| CN105031025B (en) | Compound Chinese medicinal preparation for treating porcine mycoplasmal pneumonia and preparation method thereof | |
| CN104189427B (en) | A kind of Chinese medicine composition for treating wind-cold type disease of cough and asthma and application thereof | |
| CN104998080A (en) | Traditional Chinese medicine composition for curing cough variant asthma | |
| Ye | Observation on clinical effects of tuina plus montelukast sodium tablets for children with cough variant asthma | |
| CN104887945B (en) | It is a kind of to be used to treat Chinese medicine composition of lamb pneumonia and its preparation method and application | |
| CN102688405A (en) | Bulbus fritillariae cirrhosae traditional Chinese medicine decoction for treating cough and preparation method | |
| CN108245615A (en) | A kind of composition for treating respiratory disease, suction-type Chinese medicine preparation and preparation method | |
| CN102416172A (en) | Inhalation serrapeptase preparation | |
| CN106491929A (en) | A kind of spray for treating rhinitis | |
| CN102552421A (en) | Medicament for treating stomach qi ache |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160921 |
|
| WW01 | Invention patent application withdrawn after publication |